LW
Publicaties op Oncologisch.com
First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAFV600E-mutated metastatic colorectal can...
Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: A com...
Molecular hyperselection for optimal choice of eerstelijns targeted therapy independent of primary tumor sidedness: A...
FOLFIRI with cetuximab or bevacizumab in RAS wild-type metastatic colorectal cancer: Refining eerstelijns treatment s...